This is a series on the advances in CAR T, a remarkable immunotherapy treatment dubbed a “living drug.” This new therapy genetically modifies a patient’s cells to fight cancer, but current research efforts hope to treat autoimmune diseases, organ damage and more.
“CANCER SPREAD” HAS SUCH dreadful implications. Having helped individuals with cancer for over three decades, discussions around metastases still shake me.
Fortunately, age-adjusted death rates are...
joint efforts will form best practices for non-profit health organizations to leverage patient self-reporting with the goal of advancing science, treatment and quality of life.
